| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10594272 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
In an effort to develop safe and efficacious compounds for the treatment of metabolic disorders, new compounds based on a combination of clofibric acid, the active metabolite of clofibrate, and lipophilic groups derived from natural products chalcone and stilbene were synthesised. Some of them were found to be active at micromolar concentrations only on PPARα or PPARγ, while others were identified as dual agonists PPARα/γ.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Letizia Giampietro, Alessandra D'Angelo, Antonella Giancristofaro, Alessandra Ammazzalorso, Barbara De Filippis, Marialuigia Fantacuzzi, Pasquale Linciano, Cristina Maccallini, Rosa Amoroso,